about
Toxin-Antitoxin Systems in Clinical PathogensRole of quorum sensing in bacterial infectionsGenome Sequence of Airborne Acinetobacter sp. Strain 5-2Ac02 in the Hospital Environment, Close to the Species of Acinetobacter towneriMolecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii.Response to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum SensingWhole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells.Quantitative proteomic analysis of host--pathogen interactions: a study of Acinetobacter baumannii responses to host airwaysExpression of OXA-type and SFO-1 β-lactamases induces changes in peptidoglycan composition and affects bacterial fitness.Draft Genome Sequence of the Biofilm-Hyperproducing Acinetobacter baumannii Clinical Strain MAR002.Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme.Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?Genome Sequence of a Clinical Strain of Acinetobacter baumannii Belonging to the ST79/PFGE-HUI-1 Clone Lacking the AdeABC (Resistance-Nodulation-Cell Division-Type) Efflux Pump.Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cellsDiagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology.Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).Exploiting Quorum Sensing Inhibition for the Control of Pseudomonas Aeruginosa and Acinetobacter Baumannii Biofilms.Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010)Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system.First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort.Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade.Relationship between tolerance and persistence mechanisms in Acinetobacter baumannii strains with AbkAB Toxin-Antitoxin system.Molecular characterization of the gene encoding a new AmpC beta-lactamase in Acinetobacter baylyi.Multiple Quorum Quenching Enzymes Are Active in the Nosocomial Pathogen ATCC17978Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory EnvironmentsResistencia a los antimicrobianos y virulencia, ¿una asociación beneficiosa para el mundo microbiano?Strategies to Combat Multidrug-Resistant and Persistent Infectious DiseasesCombined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumanniiMultiplex Real-Time PCR-shortTUB Assay for Detection of the Mycobacterium tuberculosis Complex in Smear-Negative Clinical Samples with Low Mycobacterial Loads
P50
Q26742021-8F9F153B-4CB5-48AC-9770-7790D93934D6Q26798427-472AA5B1-6F0D-4A85-BC42-321F5F1D3E0FQ28817740-453A8C2F-05A4-474B-8455-2AC19663A683Q31145147-FEA102D4-1969-4ACD-8735-BEAA1549778CQ33652749-439A42F5-73A3-4F3F-92BE-D3AEBB7BAF09Q34983666-5CBA24B9-DCAF-47A0-A42D-9965C40ED80FQ35646590-9A588386-728D-4AB8-8188-2E6F40112AC2Q35867391-8A28B7B8-9007-48C5-AB9A-812A296D9A07Q35883982-5638CF5B-1507-421D-999F-FCA166FCF97CQ36150941-93B3D287-8178-4701-8F17-0D546307D067Q36318434-88AE330E-C72D-44BF-8D11-51AFFD375877Q36757725-ADE32AA1-5429-4C3F-8CCC-075F82A211D7Q37244460-F5ABB57A-3071-49CD-B131-AFB2F7351FA3Q37263566-8E34F7CA-5C9E-440C-9693-23C34F52BC6BQ38962879-8957787E-3AE4-466E-9B9D-B4DFA441A56CQ39054376-602D7327-B25D-4575-A298-6F88CD1AA340Q39063637-AB85E6C6-A101-44BB-966A-A351E0A3A266Q39068609-D63ADA18-E958-4847-88CB-B32A40EDFDF2Q40334912-CF993D29-672E-41E6-A5FF-22A938CE0299Q40475902-F0FB4838-2F2D-4C37-A370-5277FCE3AA70Q42212995-6ED38C0B-C543-4E08-81BA-DC58A7B90754Q42529972-79D3A4BB-CA73-43C9-85A6-02C3ECB62F77Q46198938-00430FE2-6D95-49C3-9B3F-21B28463325DQ48081190-BE21BDFE-56BF-4F25-A08B-BE0DD6FF93CDQ48095816-9F93AC12-9C47-4E98-9DAB-D7275CEC34A9Q49792019-7BE2DB85-50EB-4486-9183-C5AE5C118D88Q54443926-93D2650B-8497-459C-984D-008F04B5A2C4Q57075103-F592EB76-1989-43CA-A65D-31B480F6C2DFQ57657193-31580A50-109F-4712-9D1C-A60D2851B8ECQ57657407-F910ADCA-213F-4200-95E9-22F8C7A66FB8Q89633449-BF0F99D8-1DCE-4940-981C-8F8D8C9F7D1AQ91282709-BF170497-EE51-4420-8751-A4ABA240026DQ92688948-03E7F63F-1AAC-4374-91D6-1776302AD7A5
P50
description
investigador
@es
researcher
@en
name
María Mar Tomás
@en
María Mar Tomás
@nl
type
label
María Mar Tomás
@en
María Mar Tomás
@nl
prefLabel
María Mar Tomás
@en
María Mar Tomás
@nl
P31
P496
0000-0003-4501-0387